Literature DB >> 25784557

The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.

Sowmya Shivanna1, Itrat Harrold2, Moshe Shashar1, Rosanna Meyer3, Chrystelle Kiang4, Jean Francis1, Qing Zhao3, Hui Feng2, Elazer R Edelman4, Nader Rahimi3, Vipul C Chitalia5.   

Abstract

Wnt signaling plays important roles in both the tumor-induced angiogenesis and tumorigenesis through the transcriptionally active nuclear β-catenin. Recently, c-Cbl was identified as a unique E3 ubiquitin ligase targeting the active nuclear β-catenin. However, little is known about the molecular mechanisms by which c-Cbl regulates ubiquitination and degradation of active β-catenin. Here, we demonstrate that Wnt activation promotes the phosphorylation of c-Cbl at tyrosine 731(Tyr-731), which increases c-Cbl dimerization and binding to β-catenin. Tyr-731 phosphorylation and dimerization mediate c-Cbl nuclear translocation and lead to the degradation of nuclearly active β-catenin in the Wnt-on phase. c-Cbl activation also inhibits expression of the pro-angiogenic Wnt targets, IL-8 and VEGF. Phospho-Tyr-731-inactive mutant c-Cbl (Y731F) enhances and phosphomimetic mutant c-Cbl (Y731E) suppresses angiogenesis in zebrafish. Taken together, we have identified a novel mechanism for the regulation of active nuclear β-catenin by c-Cbl and its critical role in angiogenesis. This mechanism can be further explored to modulate both the pathological angiogenesis and the tumorigenesis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Angiogenesis; Cbl; E3 Ubiquitin Ligase; Tumor Cell Biology; Tumorigenesis; Tumors; Wnt Signaling; Zebrafish; β-Catenin

Mesh:

Substances:

Year:  2015        PMID: 25784557      PMCID: PMC4432275          DOI: 10.1074/jbc.M114.616623

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  The role of wnt signaling in physiological and pathological angiogenesis.

Authors:  Elisabetta Dejana
Journal:  Circ Res       Date:  2010-10-15       Impact factor: 17.367

Review 2.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  β-Catenin 1 and β-catenin 2 play similar and distinct roles in left-right asymmetric development of zebrafish embryos.

Authors:  Min Zhang; Junfeng Zhang; Sheng-Cai Lin; Anming Meng
Journal:  Development       Date:  2012-04-25       Impact factor: 6.868

Review 4.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

5.  Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization.

Authors:  Deeba Husain; Rosana D Meyer; Manisha Mehta; Walther M Pfeifer; Eva Chou; Gregory Navruzbekov; Ednan Ahmed; Nader Rahimi
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-30       Impact factor: 4.799

6.  PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation.

Authors:  Rosana D Meyer; Srimathi Srinivasan; Amrik J Singh; John E Mahoney; Kobra Rezazadeh Gharahassanlou; Nader Rahimi
Journal:  Mol Cell Biol       Date:  2011-03-14       Impact factor: 4.272

7.  A role for protein ubiquitination in VEGFR-2 signalling and angiogenesis.

Authors:  Nader Rahimi
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

8.  Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.

Authors:  Jie Hu; Aiwen Dong; Veronica Fernandez-Ruiz; Juanjuan Shan; Milosz Kawa; Eduardo Martínez-Ansó; Jesus Prieto; Cheng Qian
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

9.  c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.

Authors:  R D Meyer; D Husain; N Rahimi
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

10.  Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.

Authors:  Charlotte M Niemeyer; Michelle W Kang; Danielle H Shin; Ingrid Furlan; Miriam Erlacher; Nancy J Bunin; Severa Bunda; Jerry Z Finklestein; Thomas A Gorr; Parinda Mehta; Irene Schmid; Gabriele Kropshofer; Selim Corbacioglu; Peter J Lang; Christoph Klein; Paul-Gerhard Schlegel; Andrea Heinzmann; Michaela Schneider; Jan Starý; Marry M van den Heuvel-Eibrink; Henrik Hasle; Franco Locatelli; Debbie Sakai; Sophie Archambeault; Leslie Chen; Ryan C Russell; Stephanie S Sybingco; Michael Ohh; Benjamin S Braun; Christian Flotho; Mignon L Loh
Journal:  Nat Genet       Date:  2010-08-08       Impact factor: 38.330

View more
  23 in total

1.  Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor.

Authors:  Shan Zeng; Adrian M Seifert; Jennifer Q Zhang; Michael J Cavnar; Teresa S Kim; Vinod P Balachandran; Juan A Santamaria-Barria; Noah A Cohen; Michael J Beckman; Benjamin D Medina; Ferdinand Rossi; Megan H Crawley; Jennifer K Loo; Joanna H Maltbaek; Peter Besmer; Cristina R Antonescu; Ronald P DeMatteo
Journal:  Mol Cancer Ther       Date:  2017-06-13       Impact factor: 6.261

Review 2.  Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review).

Authors:  Xiuzhen Zhang; Tong Meng; Shuaishuai Cui; Dongwu Liu; Qiuxiang Pang; Ping Wang
Journal:  Int J Oncol       Date:  2022-05-26       Impact factor: 5.884

Review 3.  Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.

Authors:  Luqing Zhao; Yitao Mao; Jianhua Zhou; Yuelong Zhao; Ya Cao; Xiang Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

4.  Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.

Authors:  Sean Richards; Joshua Walker; Masako Nakanishi; Mostafa Belghasem; Chimera Lyle; Nkiruka Arinze; Marc A Napoleon; Jonathan D Ravid; Nicholas Crossland; Qing Zhao; Daniel Rosenberg; Nader Rahimi; Vipul C Chitalia
Journal:  Am J Pathol       Date:  2020-02-26       Impact factor: 4.307

5.  E3 ligase c-Cbl regulates intestinal inflammation through suppressing fungi-induced noncanonical NF-κB activation.

Authors:  Jie-Lin Duan; Hui-Qian He; Yao Yu; Tao Liu; Shu-Jun Ma; Fan Li; Yan-Shan Jiang; Xin Lin; De-Dong Li; Quan-Zhen Lv; Hui-Hui Ma; Xin-Ming Jia
Journal:  Sci Adv       Date:  2021-05-07       Impact factor: 14.136

6.  c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.

Authors:  Sowmiya Kumaradevan; Shin Yin Lee; Sean Richards; Chimera Lyle; Qing Zhao; Umit Tapan; Yilan Jiangliu; Shmyle Ghumman; Joshua Walker; Mostafa Belghasem; Nkiruka Arinze; Angela Kuhnen; Janice Weinberg; Jean Francis; Kevan Hartshorn; Vijaya B Kolachalama; Daniel Cifuentes; Nader Rahimi; Vipul C Chitalia
Journal:  Am J Pathol       Date:  2018-07-17       Impact factor: 5.770

7.  c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.

Authors:  Minakshi Nihal; Gary S Wood
Journal:  Oncotarget       Date:  2016-08-16

8.  The Transcription Factor Bach1 Suppresses the Developmental Angiogenesis of Zebrafish.

Authors:  Li Jiang; Meng Yin; Jie Xu; Mengping Jia; Shaoyang Sun; Xu Wang; Jianyi Zhang; Dan Meng
Journal:  Oxid Med Cell Longev       Date:  2017-03-14       Impact factor: 6.543

9.  An oxygen-insensitive Hif-3α isoform inhibits Wnt signaling by destabilizing the nuclear β-catenin complex.

Authors:  Peng Zhang; Yan Bai; Ling Lu; Yun Li; Cunming Duan
Journal:  Elife       Date:  2016-01-14       Impact factor: 8.140

10.  ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.

Authors:  Shan Zeng; Adrian M Seifert; Jennifer Q Zhang; Teresa S Kim; Timothy G Bowler; Michael J Cavnar; Benjamin D Medina; Gerardo A Vitiello; Ferdinand Rossi; Jennifer K Loo; Nesteene J Param; Ronald P DeMatteo
Journal:  Oncotarget       Date:  2017-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.